Rituxan (rituximab) - Roche
methylprednisolone sodium succinate - Generic mfg.
An Unusual Overlap: Myeloperoxidase-ANCA Glomerulonephritis in Mixed Connective Tissue Disease (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0777; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Patient was treated with pulse dose intravenous methylprednisolone 500 mg daily for three days, followed by tapering dose of oral corticosteroids. She received two doses of rituximab two weeks apart...Patients with connective tissue disorders who develop ANCA-positive glomerulonephritis are predominantly female and carry higher burden of non renal relapses and venous thromboembolic events as compared to those without underlying connective tissue disease. This case highlights the importance of renal biopsy as it dictates therapeutic mangement and prognosis." 
Cardiovascular • Fibrosis • Glomerulonephritis • Immunology • Interstitial Lung Disease • Lupus Nephritis • Nephrology • Pulmonary Arterial Hypertension • Pulmonary Disease • Renal Disease • Respiratory Diseases • Rheumatology • MPO
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4559217
 
Rujul Piyush Shastri; Marcos Alejandro Rodriguez; Sanjeev Bhandari; Kisra Anis; Belinda Jim
 
Oct 2, 2026
 
Prev Next